Why the study?
Do benzyloxyphenyl NCX inhibitors prevent myocardial ischemia/reperfusion injury and salt-sensitive hypertension in animal models?
Do benzyloxyphenyl NCX inhibitors prevent myocardial ischemia/reperfusion injury and salt-sensitive hypertension in animal models?
NCX inhibitors show therapeutic potential for myocardial reperfusion injury and salt-sensitive hypertension in preclinical models, though their role in heart failure and arrhythmias remains unclear.
No takes yet. Share an insight, caveat, or question.
Supports NCX inhibitor development for I/R injury and hypertension; leaves open translation and safety in human trials.
Takahiro Iwamoto (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: